An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment
Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third...
Saved in:
Published in | ACS infectious diseases Vol. 8; no. 6; pp. 1107 - 1115 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
10.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6–8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of T. cruzi, as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure. |
---|---|
AbstractList | Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6–8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of T. cruzi, as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure. Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi . The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6–8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of T. cruzi , as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure. Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan . The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6-8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of , as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure. Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6-8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of T. cruzi, as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure.Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health Organization classifies CD as the most prevalent of poverty-promoting neglected tropical diseases, the most important parasitic one, and the third most infectious disease in Latin America. Currently, CD is a global public health issue that affects 6-8 million people. However, the current approved treatments are limited to two nitroheterocyclic drugs developed more than 50 years ago. Many efforts have been made in recent decades to find new therapies, but our limited understanding of the infection process, pathology development, and long-term nature of this disease has made it impossible to develop new drugs, effective treatment, or vaccines. This Review aims to provide a comprehensive update on our understanding of the current life cycle, new morphological forms, and genetic diversity of T. cruzi, as well as identify intervention points in the life cycle where new drugs and treatments could achieve a parasitic cure. |
Author | Marín, Clotilde Martín-Escolano, Rubén Rosales, María J. Tsaousis, Anastasios D. Martín-Escolano, Javier Medina-Carmona, Encarnación |
AuthorAffiliation | Department of Parasitology Department of Physical Chemistry School of Biosciences Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS) University Hospital Virgen del Rocío/CSIC/University of Seville Laboratory of Molecular & Evolutionary Parasitology, RAPID group, School of Biosciences |
AuthorAffiliation_xml | – name: Department of Parasitology – name: Department of Physical Chemistry – name: Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS) – name: School of Biosciences – name: University Hospital Virgen del Rocío/CSIC/University of Seville – name: Laboratory of Molecular & Evolutionary Parasitology, RAPID group, School of Biosciences |
Author_xml | – sequence: 1 givenname: Javier surname: Martín-Escolano fullname: Martín-Escolano, Javier organization: University Hospital Virgen del Rocío/CSIC/University of Seville – sequence: 2 givenname: Clotilde orcidid: 0000-0002-4316-2742 surname: Marín fullname: Marín, Clotilde organization: Department of Parasitology – sequence: 3 givenname: María J. surname: Rosales fullname: Rosales, María J. organization: Department of Parasitology – sequence: 4 givenname: Anastasios D. surname: Tsaousis fullname: Tsaousis, Anastasios D. organization: Laboratory of Molecular & Evolutionary Parasitology, RAPID group, School of Biosciences – sequence: 5 givenname: Encarnación surname: Medina-Carmona fullname: Medina-Carmona, Encarnación email: emedcar@ugr.es organization: School of Biosciences – sequence: 6 givenname: Rubén orcidid: 0000-0002-6262-9344 surname: Martín-Escolano fullname: Martín-Escolano, Rubén email: r.martin-escolano@kent.ac.uk organization: Laboratory of Molecular & Evolutionary Parasitology, RAPID group, School of Biosciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35652513$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUU1rFDEYDlKxtfYXCJKjl23zMZPMeBDKUrWwoIfVa8gmb2zKTLImmS3rrzfLbsvWg54SeJ8vnuc1OgkxAEJvKbmkhNErbbIPDoz1-ZIZQijjL9AZ45LPOsbkydH_FF3kfE8qhndt07Sv0ClvRctays-QuQ74-9rqAhb_8PCAo8PlDvAybdc6xBxHjU2afnu88A7wfGsG-IBvQ4G0gVB8DPhb9KFk7GLCOuAbV1MVv9lJgC5jBb1BL50eMlwc3nO0_HSznH-ZLb5-vp1fL2a6piqzvhNstWo1byV1QDXhUjPdG03tSjaO2VYKQiVllAvowHWCUyOMsNQa2lt-jj7uZdfTagRrqnPSg1onP-q0VVF79fwS_J36GTeqp33Tk6YKvD8IpPhrglzU6LOBYdAB4pQVE5JJIjpKKvTdsdeTyWOxFcD3AJNizgncE4QStVtQHS2oDgtWVv8Xy_iidy3XwH74D_dqz61HdR-nFGrX_2T8ASUBtjU |
CitedBy_id | crossref_primary_10_1038_s41598_024_59654_8 crossref_primary_10_3390_life13122339 crossref_primary_10_1016_j_ijppaw_2024_101021 crossref_primary_10_1021_acs_jmedchem_2c00972 crossref_primary_10_3389_fcimb_2022_1000972 crossref_primary_10_3390_pathogens14010072 crossref_primary_10_3390_plants13162177 crossref_primary_10_1021_acs_jmedchem_3c00582 crossref_primary_10_3389_fcimb_2024_1293782 crossref_primary_10_1021_acs_jnatprod_4c00567 crossref_primary_10_2174_1871520623666230529141544 crossref_primary_10_1128_mmbr_00164_22 crossref_primary_10_36660_abc_20230269 crossref_primary_10_1111_febs_17340 crossref_primary_10_3390_insects16020161 crossref_primary_10_1016_j_ejmech_2024_117203 crossref_primary_10_3390_microorganisms12040827 crossref_primary_10_3390_pathogens14020106 crossref_primary_10_1007_s10863_023_09982_7 crossref_primary_10_1089_abc_2024_0020 crossref_primary_10_3389_fcimb_2022_1057774 crossref_primary_10_3390_pharmaceutics16020227 crossref_primary_10_3390_ph18040456 crossref_primary_10_1016_j_ejmech_2022_114926 crossref_primary_10_1371_journal_pntd_0012906 crossref_primary_10_1016_j_bbih_2024_100897 crossref_primary_10_1016_j_exppara_2023_108496 crossref_primary_10_3390_ijms25073840 crossref_primary_10_3390_cells14020115 crossref_primary_10_1016_j_vprsr_2024_101163 crossref_primary_10_1002_cbdv_202401247 crossref_primary_10_3390_pharmaceutics15010140 crossref_primary_10_3390_tropicalmed10020050 crossref_primary_10_3390_diseases12100238 crossref_primary_10_1021_acs_jcim_4c01927 crossref_primary_10_1007_s10989_024_10626_6 crossref_primary_10_3390_cells11223693 crossref_primary_10_1007_s13205_023_03799_2 crossref_primary_10_1021_acsinfecdis_3c00076 crossref_primary_10_1146_annurev_micro_041222_025305 crossref_primary_10_1186_s13326_024_00307_0 crossref_primary_10_1016_j_jinorgbio_2022_112047 crossref_primary_10_1089_genbio_2024_0020 crossref_primary_10_1038_s41598_025_90088_y crossref_primary_10_1016_j_vprsr_2024_101129 crossref_primary_10_3390_inorganics11110420 crossref_primary_10_3762_bjnano_15_30 crossref_primary_10_1016_j_ejmcr_2025_100248 crossref_primary_10_1007_s10800_023_01945_5 |
Cites_doi | 10.1098/rsob.190036 10.3390/microorganisms9020406 10.1111/j.1550-7408.1982.tb05427.x 10.1590/S0001-37652008000100011 10.1111/cmi.12297 10.1073/pnas.121187198 10.1126/science.1112631 10.1038/s41467-019-11771-z 10.1177/1087057114552623 10.1371/journal.pntd.0001412 10.3389/fcell.2021.633195 10.1016/0014-4894(87)90062-2 10.1016/S0140-6736(17)31612-4 10.1371/journal.pntd.0003697 10.1016/j.ijpara.2004.10.023 10.1021/acsinfecdis.0c00353 10.1017/S0031182009005861 10.1016/S0300-8932(09)73087-8 10.1258/td.2009.090035 10.1016/j.idc.2004.01.005 10.1111/j.1574-6976.2011.00305.x 10.1073/pnas.1415109111 10.1371/journal.ppat.0020024 10.1006/scbi.2001.0382 10.3389/fpubh.2019.00166 10.1016/S1567-1348(02)00097-7 10.1016/j.ijpara.2009.04.001 10.1084/jem.20011433 10.1016/S0140-6736(10)60061-X 10.1016/S0020-7519(01)00153-9 10.1016/j.actatropica.2015.05.007 10.1515/cclm-2012-0316 10.1093/infdis/jis331 10.1590/0074-02760140401 10.1016/j.actatropica.2009.10.023 10.1371/journal.pntd.0008035 10.4161/viru.19178 10.1016/j.jacc.2016.12.023 10.1051/vetres/2009009 10.1038/nmicrobiol.2016.92 10.1038/nrd4683 10.1021/acsinfecdis.7b00208 10.1080/17460441.2018.1417380 10.3389/fcimb.2020.00005 10.1080/00034983.1965.11686277 10.1016/j.actatropica.2017.09.017 10.1590/S0074-02762009000700021 10.1111/mmi.13653 10.1590/S0074-02762010000700014 10.1177/1087057114550585 10.3390/molecules25122799 10.1017/S0031182017001469 10.1016/S0020-7519(02)00264-3 10.2174/1573403X11309020007 10.1016/j.exppara.2004.07.001 10.1017/S003118201300142X 10.2147/DDDT.S90208 10.1016/j.ejmech.2018.12.034 10.1590/S0074-02762010000200022 10.1586/14787210.2015.1056158 10.1021/acsinfecdis.1c00091 10.1016/j.meegid.2016.01.029 10.1016/j.actatropica.2019.105168 10.1056/NEJMra1410150 10.7554/eLife.34039 10.1021/acs.jmedchem.8b00468 10.1590/S0074-02761909000200008 10.3390/pathogens10111493 10.1093/jac/dkaa030 10.1590/0037-8682-0505-2016 10.1016/S1471-4922(02)02357-7 10.1016/j.pt.2011.10.005 10.1016/S0166-6851(99)00155-3 10.1016/j.cpcardiol.2019.100507 10.1016/j.exppara.2017.02.013 10.2174/1566524043360249 10.1126/science.aaf4268 10.1016/S0166-6851(00)00302-9 10.1038/nature01438 10.1099/00221287-147-12-3231 10.1016/j.bbadis.2019.165658 10.1093/cid/ciy121 10.1016/j.chom.2014.09.003 10.1016/B978-0-12-407672-3.00002-2 10.1021/acsinfecdis.8b00298 10.1186/s13071-018-2664-4 |
ContentType | Journal Article |
Copyright | 2022 The Authors. Published by American Chemical Society 2022 The Authors. Published by American Chemical Society 2022 The Authors |
Copyright_xml | – notice: 2022 The Authors. Published by American Chemical Society – notice: 2022 The Authors. Published by American Chemical Society 2022 The Authors |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1021/acsinfecdis.2c00123 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2373-8227 |
EndPage | 1115 |
ExternalDocumentID | PMC9194904 35652513 10_1021_acsinfecdis_2c00123 b263012280 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: ; grantid: NA – fundername: ; grantid: E-BIO-464-UGR20 |
GroupedDBID | 53G ABFRP ABMVS ABUCX ACGFS ACS AEESW AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ EBS GGK UI2 VF5 VG9 W1F AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV BAANH CITATION CUPRZ NPM 7X8 5PM |
ID | FETCH-LOGICAL-a445t-9862bb5a3571fe1a037a2a9ca1db74f2d57601712136e8ef8631c6c6d1dc19d3 |
IEDL.DBID | ACS |
ISSN | 2373-8227 |
IngestDate | Thu Aug 21 18:42:46 EDT 2025 Fri Jul 11 16:45:23 EDT 2025 Wed Feb 19 02:26:55 EST 2025 Thu Apr 24 22:51:46 EDT 2025 Tue Jul 01 01:32:35 EDT 2025 Mon Jun 13 03:10:41 EDT 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 6 |
Keywords | genetic diversity target product profile life cycle drug discovery morphological forms Chagas disease tropism evolution model Trypanosoma cruzi |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a445t-9862bb5a3571fe1a037a2a9ca1db74f2d57601712136e8ef8631c6c6d1dc19d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-6262-9344 0000-0002-4316-2742 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9194904 |
PMID | 35652513 |
PQID | 2672706810 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9194904 proquest_miscellaneous_2672706810 pubmed_primary_35652513 crossref_primary_10_1021_acsinfecdis_2c00123 crossref_citationtrail_10_1021_acsinfecdis_2c00123 acs_journals_10_1021_acsinfecdis_2c00123 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-10 |
PublicationDateYYYYMMDD | 2022-06-10 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS infectious diseases |
PublicationTitleAlternate | ACS Infect. Dis |
PublicationYear | 2022 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref45/cit45 ref3/cit3 ref27/cit27 ref81/cit81 ref63/cit63 ref56/cit56 ref16/cit16 ref92/cit92 ref52/cit52 ref23/cit23 ref8/cit8 ref31/cit31 ref59/cit59 ref85/cit85 ref2/cit2 ref77/cit77 ref34/cit34 ref71/cit71 ref37/cit37 ref20/cit20 ref48/cit48 ref60/cit60 ref74/cit74 ref88/cit88 ref17/cit17 ref82/cit82 ref10/cit10 ref35/cit35 ref89/cit89 Brener Z. (ref30/cit30) 1963; 5 ref53/cit53 ref19/cit19 ref93/cit93 ref21/cit21 ref42/cit42 ref96/cit96 ref49/cit49 ref13/cit13 ref61/cit61 ref75/cit75 ref67/cit67 ref24/cit24 ref38/cit38 ref90/cit90 ref50/cit50 ref64/cit64 ref78/cit78 ref54/cit54 ref6/cit6 ref36/cit36 ref18/cit18 ref83/cit83 ref65/cit65 ref79/cit79 ref11/cit11 ref25/cit25 ref29/cit29 ref72/cit72 ref76/cit76 ref86/cit86 ref32/cit32 ref39/cit39 ref14/cit14 ref57/cit57 ref5/cit5 ref51/cit51 ref43/cit43 ref80/cit80 ref28/cit28 ref40/cit40 ref68/cit68 ref94/cit94 ref91/cit91 ref26/cit26 ref55/cit55 ref73/cit73 ref69/cit69 ref12/cit12 ref15/cit15 ref62/cit62 ref66/cit66 ref41/cit41 ref58/cit58 ref95/cit95 ref22/cit22 ref33/cit33 ref87/cit87 Brener Z. (ref46/cit46) 1976; 18 ref4/cit4 ref47/cit47 ref84/cit84 ref1/cit1 ref44/cit44 ref70/cit70 ref7/cit7 |
References_xml | – ident: ref80/cit80 doi: 10.1098/rsob.190036 – ident: ref20/cit20 doi: 10.3390/microorganisms9020406 – ident: ref49/cit49 doi: 10.1111/j.1550-7408.1982.tb05427.x – ident: ref76/cit76 doi: 10.1590/S0001-37652008000100011 – ident: ref82/cit82 doi: 10.1111/cmi.12297 – ident: ref25/cit25 – ident: ref59/cit59 doi: 10.1073/pnas.121187198 – ident: ref4/cit4 – ident: ref66/cit66 doi: 10.1126/science.1112631 – ident: ref71/cit71 doi: 10.1038/s41467-019-11771-z – ident: ref81/cit81 doi: 10.1177/1087057114552623 – ident: ref85/cit85 doi: 10.1371/journal.pntd.0001412 – ident: ref44/cit44 doi: 10.3389/fcell.2021.633195 – ident: ref34/cit34 doi: 10.1016/0014-4894(87)90062-2 – ident: ref2/cit2 doi: 10.1016/S0140-6736(17)31612-4 – ident: ref96/cit96 doi: 10.1371/journal.pntd.0003697 – ident: ref48/cit48 doi: 10.1016/j.ijpara.2004.10.023 – ident: ref7/cit7 doi: 10.1021/acsinfecdis.0c00353 – ident: ref55/cit55 doi: 10.1017/S0031182009005861 – ident: ref10/cit10 doi: 10.1016/S0300-8932(09)73087-8 – ident: ref32/cit32 doi: 10.1258/td.2009.090035 – ident: ref9/cit9 doi: 10.1016/j.idc.2004.01.005 – ident: ref42/cit42 doi: 10.1111/j.1574-6976.2011.00305.x – ident: ref64/cit64 doi: 10.1073/pnas.1415109111 – ident: ref53/cit53 doi: 10.1371/journal.ppat.0020024 – ident: ref43/cit43 doi: 10.1006/scbi.2001.0382 – ident: ref5/cit5 doi: 10.3389/fpubh.2019.00166 – ident: ref58/cit58 doi: 10.1016/S1567-1348(02)00097-7 – ident: ref47/cit47 doi: 10.1016/j.ijpara.2009.04.001 – ident: ref51/cit51 doi: 10.1084/jem.20011433 – ident: ref12/cit12 doi: 10.1016/S0140-6736(10)60061-X – ident: ref29/cit29 doi: 10.1016/S0020-7519(01)00153-9 – ident: ref61/cit61 doi: 10.1016/j.actatropica.2015.05.007 – ident: ref15/cit15 doi: 10.1515/cclm-2012-0316 – ident: ref67/cit67 doi: 10.1093/infdis/jis331 – volume: 18 start-page: 450 year: 1976 ident: ref46/cit46 publication-title: Rev. Instrum. Med. Trop. Sao Paulo – ident: ref27/cit27 – ident: ref70/cit70 doi: 10.1590/0074-02760140401 – ident: ref11/cit11 doi: 10.1016/j.actatropica.2009.10.023 – ident: ref94/cit94 doi: 10.1371/journal.pntd.0008035 – ident: ref91/cit91 doi: 10.4161/viru.19178 – ident: ref17/cit17 doi: 10.1016/j.jacc.2016.12.023 – ident: ref74/cit74 doi: 10.1051/vetres/2009009 – ident: ref14/cit14 doi: 10.1038/nmicrobiol.2016.92 – ident: ref87/cit87 doi: 10.1038/nrd4683 – ident: ref95/cit95 doi: 10.1021/acsinfecdis.7b00208 – ident: ref89/cit89 doi: 10.1080/17460441.2018.1417380 – ident: ref38/cit38 doi: 10.3389/fcimb.2020.00005 – ident: ref31/cit31 doi: 10.1080/00034983.1965.11686277 – ident: ref26/cit26 – ident: ref56/cit56 doi: 10.1016/j.actatropica.2017.09.017 – ident: ref54/cit54 doi: 10.1590/S0074-02762009000700021 – ident: ref45/cit45 doi: 10.1111/mmi.13653 – ident: ref69/cit69 doi: 10.1590/S0074-02762010000700014 – ident: ref88/cit88 doi: 10.1177/1087057114550585 – ident: ref93/cit93 doi: 10.3390/molecules25122799 – ident: ref35/cit35 doi: 10.1017/S0031182017001469 – ident: ref60/cit60 doi: 10.1016/S0020-7519(02)00264-3 – ident: ref3/cit3 doi: 10.2174/1573403X11309020007 – ident: ref24/cit24 – ident: ref68/cit68 doi: 10.1016/j.exppara.2004.07.001 – ident: ref86/cit86 doi: 10.1017/S003118201300142X – ident: ref18/cit18 – ident: ref21/cit21 doi: 10.2147/DDDT.S90208 – ident: ref6/cit6 – ident: ref78/cit78 doi: 10.1016/j.ejmech.2018.12.034 – ident: ref84/cit84 doi: 10.1590/S0074-02762010000200022 – volume: 5 start-page: 220 year: 1963 ident: ref30/cit30 publication-title: Rev. Inst. Med. Trop. Sao Paulo – ident: ref73/cit73 doi: 10.1586/14787210.2015.1056158 – ident: ref92/cit92 doi: 10.1021/acsinfecdis.1c00091 – ident: ref57/cit57 doi: 10.1016/j.meegid.2016.01.029 – ident: ref1/cit1 – ident: ref23/cit23 doi: 10.1016/j.actatropica.2019.105168 – ident: ref28/cit28 doi: 10.1056/NEJMra1410150 – ident: ref37/cit37 doi: 10.7554/eLife.34039 – ident: ref77/cit77 doi: 10.1021/acs.jmedchem.8b00468 – ident: ref8/cit8 doi: 10.1590/S0074-02761909000200008 – ident: ref83/cit83 doi: 10.3390/pathogens10111493 – ident: ref79/cit79 doi: 10.1093/jac/dkaa030 – ident: ref13/cit13 doi: 10.1590/0037-8682-0505-2016 – ident: ref65/cit65 doi: 10.1016/S1471-4922(02)02357-7 – ident: ref41/cit41 doi: 10.1016/j.pt.2011.10.005 – ident: ref50/cit50 doi: 10.1016/S0166-6851(99)00155-3 – ident: ref19/cit19 doi: 10.1016/j.cpcardiol.2019.100507 – ident: ref33/cit33 doi: 10.1016/j.exppara.2017.02.013 – ident: ref16/cit16 doi: 10.2174/1566524043360249 – ident: ref40/cit40 doi: 10.1126/science.aaf4268 – ident: ref52/cit52 doi: 10.1016/S0166-6851(00)00302-9 – ident: ref62/cit62 doi: 10.1038/nature01438 – ident: ref63/cit63 doi: 10.1099/00221287-147-12-3231 – ident: ref22/cit22 doi: 10.1016/j.bbadis.2019.165658 – ident: ref72/cit72 doi: 10.1093/cid/ciy121 – ident: ref36/cit36 doi: 10.1016/j.chom.2014.09.003 – ident: ref39/cit39 doi: 10.1016/B978-0-12-407672-3.00002-2 – ident: ref90/cit90 doi: 10.1021/acsinfecdis.8b00298 – ident: ref75/cit75 doi: 10.1186/s13071-018-2664-4 |
SSID | ssj0001385445 |
Score | 2.479423 |
SecondaryResourceType | review_article |
Snippet | Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi. The World Health... Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan . The World Health Organization... Chagas disease (CD) is a parasitic, systemic, chronic, and often fatal illness caused by infection with the protozoan Trypanosoma cruzi . The World Health... |
SourceID | pubmedcentral proquest pubmed crossref acs |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1107 |
SubjectTerms | Review |
Title | An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment |
URI | http://dx.doi.org/10.1021/acsinfecdis.2c00123 https://www.ncbi.nlm.nih.gov/pubmed/35652513 https://www.proquest.com/docview/2672706810 https://pubmed.ncbi.nlm.nih.gov/PMC9194904 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swELe2Tpr2AvuEwpg8aQ97WDp_xHbDG6pAbBpo0srEW-T4Q0RAgppUiP71nJO0tIAQz7FPyuXO94vv7ncIfSNOecuUjjT3JIrtMIu0pyYiXHDDLI2pDb3DR8fy8CT-fSpOl5rV72XwGf2pTdXUJdm8GjDTYICX6BWT4MYBCY3-3V2p8GGglmnGySkeQehTc56hx-WEiGSq1Yj0AGber5ZcCj8H6-h43sTTVp2cD6Z1NjCzh5yOz3uzt2itA6J4r7Wcd-iFK96j10ddqv0DMnsFPrkK9wEW_8_dNS49BrCIx5MbOEDKqrzU2Eymsxz_yb3DoxuQsot_LZVQ4r9lXtQVBliMdYFbnmQ4XEFEV9z-EY0P9sejw6ibyBBpUGwdJfD_k2VCc6God1QTrjTTidHUZir2zIpQYqMCTZx0Q-eHklMjjbTUGppY_gn1irJwmwhr6YQjxAkjRWiszqR1ccw8Dw0rmRJ99B3Uk3YOVaVNrpzRdElnaaezPmLz75eajtg8zNe4eHrTj8Wmq5bX4-nlX-eGkYL_haSKLlw5hQUhlU0Cq1sfbbSGshDIAS0DfoTdasWEFgsCt_fqkyI_azi-E5rECYm3nq-GbfSGhdaMMFeJfEa9ejJ1OwCY6uxL4ya353ITww |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEF5BkaAX3pTwXCQOHHDYh9cbc4siqhSSCokE9Wat9yEswK5iR6j99cw4TpoUVMHV3h3Z49mdzzsz3xDymnkdnNAmMjKwKHaDPDKB24hJJa1wPOYOa4enx8l4Hn88USddURjWwsBD1CCpboP4F-wC_B1ca9OTXFH3hW2hwHVyA-CIQLsejr5cnKzIATLMtF3ltIzAA-o13dDf5aBjsvWuY_oDbV5OmtzyQod3yHzz_G3yyff-ssn79vwSteP_vuBdcruDpXS4sqN75Jov75Ob0y7w_oDYYUnnp3g64OjXwv-iVaAAHelscQbbSVVXPw21i-V5QSdF8HR0BlLe06OthEr6uSrKpqYAkqkp6Yo1GbZaENGluj8ks8MPs9E46vozRAb020Qp_A3luTJSaR48N0xqI0xqDXe5joNwChNuNJLGJX7gwyCR3CY2cdxZnjr5iOyVVekfE2oSrzxjXtlEYZl1njgfxyJILF_JteqRN6CerFteddZGzgXPtnSWdTrrEbH-jJntaM6x28aPqye93Uw6XbF8XD381do-MliNGGIxpa-WMAAD2ww53nrkYGUvG4ESjVVxmK13LGkzAJm-d--UxbeW8TvlaZyy-Mm_q-EluTWeTSfZ5Oj401OyL7BoAzsusWdkr1ks_XOAUk3-ol05vwHcDxwk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NIU28wPgaBQZG4oEH0vkjiRPeqkK1wTZNokPjKXL8oUUbSdWkQttfzzlNSzvQhHhN7FN8vvNdfHe_A3hLrXSGSxUo4WgQmiQPlGM6oCISmhsWMuNrh4-O4_3T8PNZdLYByaIWBj-iRkp1G8T3Wj0xrkMYYHv4vE1RMkXd57p1B-7AXR-487I9GH79fbsiEo8y03aWkyJAKygXkEN_p-ONk67XjdMfHufNxMkVSzR6AN-Xa2gTUC76sybv6-sb8I7_s8htuN-5p2Qwl6eHsGHLR7B11AXgH4MelOR04m8JDPlW2J-kcgRdSDKeXuGxUtXVD0X0dHZdkMPCWTK8QiofyMFKYiU5qYqyqQk6y0SVZI6ejEcukuhS3p_AePRpPNwPuj4NgUIeN0GKf0V5HikRSeYsU1RIxVWqFTO5DB03kU-8kR48LraJdUksmI51bJjRLDXiKWyWVWmfAVGxjSylNtJx5Mut89jYMORO-DKWXEY9eIfsyTo1q7M2gs5ZtsKzrONZD_hiKzPdwZ37rhuXt096v5w0maN93D78zUJGMtRKH2pRpa1mOMAHuKnHeuvBzlxmlgQFCix6lThbrknTcoBH_F5_UxbnLfJ3ytIwpeHzf2fDa9g6-TjKDg-Ov7yAe9zXbvjGS_QlbDbTmd1Fj6rJX7XK8wvmEB6n |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Updated+View+of+the+Trypanosoma+cruzi+Life+Cycle%3A+Intervention+Points+for+an+Effective+Treatment&rft.jtitle=ACS+infectious+diseases&rft.au=Mart%C3%ADn-Escolano%2C+Javier&rft.au=Mar%C3%ADn%2C+Clotilde&rft.au=Rosales%2C+Mar%C3%ADa+J.&rft.au=Tsaousis%2C+Anastasios+D.&rft.date=2022-06-10&rft.pub=American+Chemical+Society&rft.eissn=2373-8227&rft.volume=8&rft.issue=6&rft.spage=1107&rft.epage=1115&rft_id=info:doi/10.1021%2Facsinfecdis.2c00123&rft_id=info%3Apmid%2F35652513&rft.externalDocID=PMC9194904 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8227&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8227&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8227&client=summon |